Cencora’s VP of Emerging Therapies talks about innovative order-to-cash solutions for cell and gene therapy

In an interview with Pharm Exec Associate Editor Don Tracy and Melissa Lattanzi, Vice President of Emerging Therapies, Cecora discusses how innovative order-to-cash solutions can help maximize market reach. Talk about the process of coming up with ideas.